Zenas BioPharma, Inc. , a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.
Zenas Biopharma stock last closed at $19.07, up 4.52% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Zenas Biopharma stock is currently +227.02% from its 52-week low of $5.83, and -27.37% from its 52-week high of $26.25.
At the moment, there are 42.11M ZBIO shares outstanding. The market cap of ZBIO is $802.83M. In the past 24 hours, 242,000 ZBIO shares were traded.
How to Buy Zenas Biopharma Stock
Not sure how to invest in Zenas Biopharma stock? Here's how.
Choose where to buy Zenas Biopharma stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Zenas Biopharma stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Choose your method of payment and add your info.
Research Zenas Biopharma stock: The Zenas Biopharma ticker symbol is ZBIO. Is Zenas Biopharma stock a good investment? Should you buy shares of ZBIO? How do ZBIO's underlying business fundamentals look? Do top analysts think Zenas Biopharma is a good buy? Why has ZBIO's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if ZBIO is a good stock to buy).
Execute your ZBIO trade: Decide if you will purchase ZBIO shares at the current market price or use a limit order to purchase ZBIO shares at a specific price.
Get key alerts regarding your ZBIO position: Create a watchlist to track your position in Zenas Biopharma stock.
Step 1: Choose where to buy Zenas Biopharma stock
You need a brokerage account in order to access the NASDAQ market and buy ZBIO stock.
A brokerage account enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've chosen the best brokerage, you need to fill out some personal information so you can buy ZBIO today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Zenas Biopharma stock
After you have identified the best place to buy Zenas Biopharma stock, it's very important to evaluate their stock prior to buying, so you truly understand the risk and upside.
Zenas Biopharma stock data
ZBIO Price
$19.07
1w %
-3.66%
1y %
N/A
5y %
N/A
P/E
1.93x
P/B
3.35x
P/S
53.25x
PEG
N/A
Revenue
$15.00M
Earnings
-$177.01M
Fore. Rev. Growth
56.78%
Fore. Earn. Growth
N/A
Market Cap
$802.83M
Next Earnings
Nov 11, 2025
Next Dividend
N/A
ZBIO Due Diligence Score
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis in less time.
Last year, ZBIO revenue was $15.00M. Over the last 1 years, ZBIO's revenue has increased by -70% per year. This was slower than the Biotechnology industry average of 66.41%.
Over the last year, insiders at ZBIO have bought more shares than they have sold.
Leon O. Moulder Jr., Chief Executive Officer of ZBIO, was the latest ZBIO insider to buy. They bought $166,750.00 worth of ZBIO shares on Feb 18, 2025.
No, Zenas Biopharma doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your ZBIO trade
There are two main order types:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are usually the easiest way to buy.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a specific price limit, place a limit order.
Hit the Open button and eToro will place the order.
If you require additional help investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Zenas Biopharma share?
As of Sep 17, 2025, it costs $19.07 to buy one share of Zenas Biopharma stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $9, you can buy 0.472 shares of ZBIO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.